a test to detect insulin-producing tumors; after a 1-g intravenous dose of tolbutamide, plasma insulin and glucose are measured at intervals up to 3 hours; higher insulin responses and lower glucose values characterize patients with such tumors.
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
